World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
10078
World Ranking
3981
National Ranking
170

Stephen B. Lambert publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stephen B. Lambert sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 230 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stephen B. Lambert D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen B. Lambert sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stephen B. Lambert is affiliated with the Australian National University in Australia. Their research primarily falls within the field of Medicine, with a strong focus on subfields such as Epidemiology, Infectious Diseases, Health, Modeling and Simulation, and Physiology.

The scientist's work covers a range of main topics including respiratory viral infections research, vaccine coverage and hesitancy, viral gastroenteritis research and epidemiology, influenza virus research studies, COVID-19 epidemiological studies, pneumonia and respiratory infections, and virology and viral diseases.

The following recent papers exemplify Lambert's research contributions:

  • Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study (2020), published in The Lancet Infectious Diseases
  • Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation (2021), published in Scientific Reports
  • Respiratory virus detection during the COVID-19 pandemic in Queensland, Australia (2021), published in Australian and New Zealand Journal of Public Health
  • Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2016-2019 (2023), published in Communicable Diseases Intelligence
  • Maternal Pertussis Vaccination, Infant Immunization, and Risk of Pertussis (2023), published in PEDIATRICS

Lambert frequently collaborates with other researchers. Notable coauthors include:

  • Robert S. Ware
  • Keith Grimwood
  • Peter D. Sly
  • Davoud Pourmarzi
  • Frank Beard

The scientist has published repeatedly in several academic venues, with the most frequent outlets being:

  • Communicable Diseases Intelligence
  • Vaccine
  • Australian and New Zealand Journal of Public Health
  • Pediatric Pulmonology
  • SSRN Electronic Journal

Best Publications

  • Identification of a novel polyomavirus from patients with acute respiratory tract infections.

    Anne M Gaynor;Michael D Nissen;David M Whiley;Ian M Mackay

  • Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

    Sarah L. Sheridan;Robert S. Ware;Keith Grimwood;Stephen B. Lambert

  • Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.

    Jim P. Buttery;Jim P. Buttery;Stephen B. Lambert;Stephen B. Lambert;Keith Grimwood;Keith Grimwood;Michael D. Nissen;Michael D. Nissen

  • Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia

    Elizabeth Crowe;Nirmala Pandeya;Julia M L Brotherton;Annette J Dobson

  • Effect of Immune Globulin on the Prevention of Experimental Hepatitis C Virus Infection

    Krzysztof Krawczynski;Miriam J. Alter;Donald L. Tankersley;Michael Beach

  • Characterisation of a newly identified human rhinovirus, HRV-QPM, discovered in infants with bronchiolitis.

    P. McErlean;P. McErlean;L.A. Shackelton;S.B. Lambert;S.B. Lambert;M.D. Nissen

  • Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial

    Terry Nolan;Jodie McVernon;Maryanne Skeljo;Peter Richmond

  • Do rhinoviruses reduce the probability of viral co-detection during acute respiratory tract infections?

    R.M. Greer;P. McErlean;P. McErlean;K.E. Arden;K.E. Arden;C.E. Faux;C.E. Faux

  • Comparing nose-throat swabs and nasopharyngeal aspirates collected from children with symptoms for respiratory virus identification using real-time polymerase chain reaction.

    Stephen B. Lambert;David M. Whiley;Nicholas T. O'Neill;Emily C. Andrews

  • Incidence of Hepatitis B Virus Infection in the United States, 1976–1994: Estimates from the National Health and Nutrition Examination Surveys

    Patrick J. Coleman;Geraldine M. McQuillan;Linda A. Moyer;Stephen B. Lambert

  • Distinguishing molecular features and clinical characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C).

    Peter McErlean;Peter McErlean;Laura A. Shackelton;Emily Andrews;Emily Andrews;Dale R. Webster

  • Community Epidemiology of Human Metapneumovirus, Human Coronavirus NL63, and Other Respiratory Viruses in Healthy Preschool-Aged Children Using Parent-Collected Specimens

    Stephen B. Lambert;Kelly M. Allen;Julian D. Druce;Chris J. Birch

  • Emerging respiratory agents: New viruses for old diseases?

    T.P. Sloots;T.P. Sloots;D.M. Whiley;D.M. Whiley;S.B. Lambert;S.B. Lambert;M.D. Nissen;M.D. Nissen

  • Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland

    Stephen B Lambert;Cassandra E Faux;Lisa Hall;Frances A Birrell

  • Pentavalent Rotavirus Vaccine and Prevention of Gastroenteritis Hospitalizations in Australia

    Emma J. Field;Hassan Vally;Keith Grimwood;Stephen B. Lambert

  • Detection of novel influenza A(H1N1) virus by real-time RT-PCR.

    David M. Whiley;David M. Whiley;Seweryn Bialasiewicz;Seweryn Bialasiewicz;Cheryl Bletchly;Cassandra E. Faux;Cassandra E. Faux

  • Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study.

    Elliott Geoffrey Playford;Elliott Geoffrey Playford;Trent Munro;Stephen M Mahler;Suzanne Elliott

  • Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.

    Sarah L Sheridan;Katie Frith;Thomas L Snelling;Keith Grimwood

  • Merkel cell polyomavirus DNA in respiratory specimens from children and adults

    Seweryn Bialasiewicz;Stephen B. Lambert;David M. Whiley;Michael D. Nissen

  • Presence of the newly discovered human polyomaviruses KI and WU in Australian patients with acute respiratory tract infection

    S. Bialasiewicz;S. Bialasiewicz;D.M. Whiley;D.M. Whiley;S.B. Lambert;S.B. Lambert;K. Jacob;K. Jacob

  • Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland, Australia

    Stephen B. Lambert;Cassandra E. Faux;L. Hall;F. E. Birrell

Frequent Co-Authors

Michael D. Nissen
Michael D. Nissen University of Queensland
Theo P. Sloots
Theo P. Sloots University of Queensland
David M. Whiley
David M. Whiley University of Queensland
Keith Grimwood
Keith Grimwood Griffith University
Terry Nolan
Terry Nolan University of Melbourne
Ian M. Mackay
Ian M. Mackay University of Queensland
Peter Richmond
Peter Richmond University of Western Australia
Robert Booy
Robert Booy University of Sydney
Heath Kelly
Heath Kelly Australian National University
Graeme R. Nimmo
Graeme R. Nimmo Griffith University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare. Many professionals consider advancing their skills through specialized nursing programs. For example, individuals aiming to enhance their practice in mental health can explore the cheapest online pmhnp certificate programs, which offer affordable routes to becoming Psychiatric-Mental Health Nurse Practitioners.

Nurse practitioners often seek further certification to specialize. Transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner is a common career move, and detailed guidance is available on how to make this shift effectively through the fnp to acute care certification pathway. Such certifications can significantly broaden clinical expertise.

Accelerated programs are also popular for registered nurses wishing to become nurse practitioners quickly. The accelerated rn to np programs are designed to fast-track this transition, allowing students to enter advanced practice roles sooner while maintaining flexibility through online study options.

Understanding potential earnings is crucial for long-term planning. According to reports on how much does a dnp make, Doctor of Nursing Practice (DNP) holders typically enjoy competitive salaries that vary by state, reflecting the demand and specialization of their skills in the healthcare market.

Best Scientists Citing Stephen B. Lambert

Trending Scientists

Recently Published Articles